GRAL GRAIL, Inc. - Common Stock
Sobre GRAIL, Inc. - Common Stock Visão geral da empresa da Wikipedia
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
Ler mais
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
In June 2021 GRAIL launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023 EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024.
Activities
Illumina's own research showed that repeatedly sequencing DNA in the bloodstream made it possible to detect floating bits of DNA from cancer cells more accurately. It initially aimed to recruit greater than 100,000 people into its clinical trials in order to accumulate the sizeable data required to detect and interpret cancer biomarkers.
Galleri test
As of November 2020 Galleri investigated three multi-cancer screening tests.
In June 2021 Galleri launched their liquid biopsy or multi-cancer early detection test (MCED), which Grail called the Galleri test. Grail promoted the test as a "groundbreaking and potentially life-saving advance", although the results of early trials were poor. A subsequent large-scale NHS England trial was described as overhyped and unethical. As of 2024, Grail was facing discontent and legal action from investors.
In June 2025, an article in the New Yorker discussed an interview of their medicine and science writer regarding the test and its recent history with a focus on its potential for adaptation as research continues in its product development through clinical investigations.
On 17 October 2025, BBC news carried positive coverage of test results just presented at the European Society for Medical Oncology. However, as of October 20, 2025 the results of the PATHFINDER 2 study have yet to be peer reviewed or published. Eric Topol reported a sensitivity of only 40% these false negatives failed to discover cancer that emerged during the 12-month follow-up.
Company history
Grail began as a San Francisco biotechnology and pharmaceutical startup company in 2015, the parent company being Illumina of San Diego, which produces most of the DNA sequencing machines that scientists use to study human biology and diagnose rare genetic diseases. Richard Klausner, then chief medical officer at Illumina and former director of the National Cancer Institute, advocated for the new business. According to the San Francisco Business Times, he correctly predicted how DNA sequencing technology would make it possible to detect evidence of a tumor from a blood sample. He also joined Grail's board of directors. According to Forbes in 2017, 20% of Grail's profits are kept by Illumina.
In September 2020, Illumina announced an agreement to purchase Grail outright for $7.1 billion.
On November 27, 2020, Grail announced a commercial partnership with the National Health Service (England) (NHS), to trial the Galleri test, reporting in 2026.
In March 2021, the Federal Trade Commission (FTC) sued to block the vertical merger. In September 2022, an administrative judge ruled against the FTC's position on antitrust grounds.
In June 2023, Grail disclosed that letters were mailed to 408 patients incorrectly informing them that they may have cancer. The company blamed the incident on PWNHealth, saying that it was due to a software configuration issue, not due to incorrect Galleri test results.
In October 2023, the European Commission ordered Grail to be divested from Illumina within the next twelve months. The European Commission (EC) has since approved Illumina's divestment plan for separating from Grail. Illumina has set a goal of finalizing the divestment terms by the end of the second quarter of 2024. In April 2024, the EC approved Illumina's plan, allowing Illumina to explore either a trade sale or a capital markets transaction (spin-off) to divest Grail. In May 2024, Illumina publicly filed a Form 10 registration statement with the U.S. SEC, a necessary step for a potential capital markets separation of Grail. If a capital markets transaction occurs, Illumina must capitalize Grail with around $1 billion to fund 2.5 years of operations per the EC's divestment plan. The spinoff was completed in June 2024, with Grail trading on the Nasdaq with ticker symbol GRAL and Illumina retaining a 14.5% share of Grail.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
GRAL Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
GRAL Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
GRAL Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
- Compra forte 4 26,7%
- Compra 5 33,3%
- Manter 6 40,0%
- Venda 0 0,0%
- Venda forte 0 0,0%
Preço-alvo de 12 meses
8 analistas · 2026-08-19Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Junho de 2026 | $-2.56 | $-2.71 | 0.15% |
| 31 de Março de 2026 | $-2.29 | $-2.82 | 0.53% |
| 31 de Dezembro de 2025 | $-2.44 | $-2.76 | 0.32% |
| 30 de Setembro de 2025 | $-2.46 | $-3.59 | 1.1% |
| 30 de Junho de 2025 | $-3.18 | $-3.64 | 0.46% |
| 31 de Março de 2025 | $-3.10 | $-4.17 | 1.1% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | — |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | — |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | — |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | — |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | — |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | — |
| IMNM | $2.43B | -8.8 | -23.2% | -3060.0% | -47.0% | — |
| IRON | $3.01B | -13.2 | — | — | -31.3% | — |
| NRIX | $1.80B | -5.8 | 53.9% | -314.9% | -53.6% | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 15
| Métrica | Tendência | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $147M | $126M | $93M | |
| R&D Expense | $196M | $322M | $339M | |
| SG&A Expense | $159M | $214M | $200M | |
| Operating Expenses | $709M | $2.31B | $1.61B | |
| Operating Income | $-562M | $-2.19B | $-1.52B | |
| Interest Income | $29M | $27M | $8M | |
| Other Non-op | $-993.0K | $64.0K | $-208.0K | |
| Pretax Income | $-535M | $-2.16B | $-1.51B | |
| Income Tax | $-126M | $-135M | $-42M | |
| Net Income | $-408M | $-2.03B | $-1.47B | |
| EPS (Basic) | $-11.11 | $-63.54 | $-47.21 | |
| EPS (Diluted) | $-11.11 | $-63.54 | $-47.21 | |
| Shares (Basic) | 36,753,751 | 31,901,259 | 31,049,148 | |
| Shares (Diluted) | 36,753,751 | 31,901,259 | 31,049,148 | |
| EBITDA | $-562M | $-2.19B | · |
Balanço Patrimonial 25
| Métrica | Tendência | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $250M | $214M | $97M | |
| Receivables | $18M | $20M | $17M | |
| Prepaid Expense | $15M | $17M | $20M | |
| Current Assets | $954M | $820M | $156M | |
| PP&E (Net) | $52M | $69M | $85M | |
| PP&E (Gross) | $122M | $123M | $121M | |
| Accum. Depreciation | $70M | $54M | $36M | |
| Goodwill | · | $0 | $889M | |
| Intangibles | $1.85B | $2.02B | $2.69B | |
| Other Non-current Assets | $7M | $8M | $8M | |
| Total Assets | $2.92B | $2.98B | $3.91B | |
| Accounts Payable | $2M | $5M | $20M | |
| Accrued Liabilities | $64M | $57M | $74M | |
| Current Liabilities | $80M | $77M | $164M | |
| Capital Leases | $43M | $55M | $70M | |
| Deferred Tax | $219M | $346M | $33M | |
| Other Non-current Liabilities | $3M | $2M | $1M | |
| Total Liabilities | $344M | $480M | $268M | |
| Common Stock | $40.0K | $34.0K | · | |
| Paid-in Capital | $12.79B | $12.31B | · | |
| Retained Earnings | $-10.21B | $-9.80B | $-7.78B | |
| AOCI | $3M | $1M | $1M | |
| Stockholders' Equity | $2.58B | $2.50B | · | |
| Liabilities + Equity | $2.92B | $2.98B | $3.91B | |
| Shares Outstanding | 40,331,360 | 33,893,409,000 | 0 |
Fluxo de Caixa 10
| Métrica | Tendência | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $58M | $86M | $97M | |
| Deferred Tax | $-126M | $-134M | $-38M | |
| Amort. of Intangibles | $134M | $134M | $134M | |
| Operating Cash Flow | $-299M | $-577M | $-596M | |
| CapEx | $909.0K | $5M | $13M | |
| Investing Cash Flow | $-85M | $-551M | $-13M | |
| Financing Cash Flow | $423M | $1.24B | $464M | |
| Net Change in Cash | $39M | $116M | $-145M | |
| Taxes Paid | $1M | · | · | |
| Free Cash Flow | $-300M | $-582M | · |
Lucratividade 7
| Métrica | Tendência | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | -382.0% | -1743.0% | · | |
| Net Margin | -277.5% | -1613.9% | · | |
| Pretax Margin | -363.2% | -1721.7% | · | |
| EBITDA Margin | -382.0% | -1743.0% | · | |
| ROA | -13.8% | -58.8% | · | |
| ROE | -16.7% | -79.6% | · | |
| ROIC | -16.7% | -82.0% | · |
Liquidez e Solvência 2
| Métrica | Tendência | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 12.0 | 10.7 | · | |
| Quick Ratio | 3.4 | 3.0 | · |
Eficiência 2
| Métrica | Tendência | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | |
| Receivables Turnover | 7.6 | 6.7 | · |
Taxas de Crescimento 2
| Métrica | Tendência | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue YoY | 17.2% | 34.9% | 67.6% | |
| Revenue CAGR 3Y | 38.4% | · | · |
Avaliação (TTM) 10
| Métrica | Tendência | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $147M | $126M | · | |
| Net Income TTM | $-408M | $-2.03B | · | |
| Market Cap | $3.45B | $605M | · | |
| P/E | -7.7 | -0.3 | · | |
| P/S | 23.5 | 4.8 | · | |
| P/B | 1.3 | 0.2 | · | |
| P / Tangible Book | 4.7 | 1.2 | · | |
| P / Cash Flow | -11.5 | -1.0 | · | |
| P / FCF | -11.5 | -1.0 | · | |
| Earnings Yield | -13.0% | -356.0% | · |
Demonstração de Resultados 15
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $45M | $41M | $44M | $36M | $36M | $32M | $38M | $29M | $32M | $27M | $30M | $21M | |
| R&D Expense | $47M | $48M | $47M | $49M | $47M | $54M | $48M | $78M | $94M | $102M | · | · | |
| SG&A Expense | $51M | $43M | $39M | $37M | $38M | $45M | $42M | $47M | $67M | $57M | · | · | |
| Operating Expenses | $218M | $177M | $168M | $161M | $194M | $185M | $175M | $212M | $1.67B | $254M | $225M | $933M | |
| Operating Income | $-174M | $-136M | $-124M | $-125M | $-159M | $-154M | $-137M | $-184M | $-1.64B | $-227M | $-195M | $-912M | |
| Interest Income | $7M | $8M | $8M | $6M | $7M | $8M | $9M | $12M | $3M | $3M | $1M | $3M | |
| Other Non-op | $-155.0K | $256.0K | $-64.0K | $466.0K | $-811.0K | $-584.0K | $578.0K | $-561.0K | $5.0K | $42.0K | $213.0K | $-196.0K | |
| Pretax Income | $-167M | $-128M | $-117M | $-119M | $-153M | $-146M | $-127M | $-172M | $-1.64B | $-224M | $-193M | $-910M | |
| Income Tax | $-56M | $-34M | $-17M | $-30M | $-39M | $-40M | $-30M | $-47M | $-53M | $-6M | $-6M | $-19M | |
| Net Income | $-110M | $-93M | $-99M | $-89M | $-114M | $-106M | $-97M | $-126M | $-1.59B | $-219M | $-885M | $-891M | |
| EPS (Basic) | $-2.56 | $-2.29 | $-2.37 | $-2.46 | $-3.18 | $-3.10 | $-1.49 | $-3.94 | $-51.06 | $-7.05 | $-6.04 | $-28.71 | |
| EPS (Diluted) | $-2.56 | $-2.29 | $-2.37 | $-2.46 | $-3.18 | $-3.10 | $-1.49 | $-3.94 | $-51.06 | $-7.05 | $-6.04 | $-28.71 | |
| Shares (Basic) | 43,112,595 | 40,640,879 | -69,472,094 | 36,124,256 | 35,793,154 | 34,308,435 | -62,077,091 | 31,880,054 | 31,049,148 | 31,049,148 | 0 | 0 | |
| Shares (Diluted) | 43,112,595 | 40,640,879 | -69,472,094 | 36,124,256 | 35,793,154 | 34,308,435 | -62,077,091 | 31,880,054 | 31,049,148 | 31,049,148 | 0 | 0 | |
| EBITDA | $-174M | $-136M | · | $-125M | $-159M | $-154M | · | $-184M | $-1.64B | · | · | · |
Balanço Patrimonial 25
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $56M | $69M | $250M | $127M | $127M | $134M | $214M | $854M | $959M | · | $97M | · | |
| Receivables | $20M | $20M | $18M | $16M | $16M | $19M | $20M | · | · | · | · | · | |
| Prepaid Expense | $16M | $17M | $15M | $15M | $13M | $15M | $17M | $20M | $21M | · | · | · | |
| Current Assets | $915M | $877M | $954M | $589M | $652M | $728M | $820M | $910M | $1.02B | · | · | · | |
| PP&E (Net) | $44M | $48M | $52M | $56M | $60M | $65M | $69M | · | · | · | · | · | |
| PP&E (Gross) | · | · | $122M | · | · | · | $123M | · | · | · | · | · | |
| Accum. Depreciation | · | · | $70M | · | · | · | $54M | · | · | · | · | · | |
| Goodwill | · | · | · | · | · | · | $0 | $0 | $0 | · | $889M | · | |
| Intangibles | $1.78B | $1.82B | $1.85B | $1.89B | $1.92B | $1.98B | $2.02B | $2.05B | $2.09B | · | · | · | |
| Other Non-current Assets | $7M | $7M | $7M | $7M | $7M | $7M | $8M | $8M | $8M | · | · | · | |
| Total Assets | $2.84B | $2.80B | $2.92B | $2.60B | $2.70B | $2.85B | $2.98B | $3.12B | $3.27B | · | · | · | |
| Accounts Payable | $7M | $5M | $2M | $3M | $6M | $6M | $5M | · | · | · | · | · | |
| Accrued Liabilities | $64M | $58M | $64M | $58M | $49M | $54M | $57M | $69M | $57M | · | · | · | |
| Current Liabilities | $84M | $75M | $80M | $77M | $71M | $75M | $77M | $94M | $88M | · | · | · | |
| Capital Leases | $81M | $41M | $43M | $45M | $48M | $51M | $55M | $59M | $62M | · | · | · | |
| Deferred Tax | $134M | $184M | $219M | $236M | $266M | $305M | $346M | $375M | $422M | · | · | · | |
| Other Non-current Liabilities | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | · | · | · | |
| Total Liabilities | $301M | $303M | $344M | $361M | $388M | $434M | $480M | $530M | $575M | · | · | · | |
| Common Stock | $45.0K | $41.0K | $40.0K | $36.0K | $36.0K | $35.0K | $34.0K | $33.0K | $31.0K | · | · | · | |
| Paid-in Capital | $12.96B | $12.80B | $12.79B | $12.35B | $12.34B | $12.32B | $12.31B | $12.29B | $12.27B | · | · | · | |
| Retained Earnings | $-10.42B | $-10.30B | $-10.21B | $-10.11B | $-10.02B | $-9.91B | $-9.80B | $-9.71B | $-9.58B | · | · | · | |
| AOCI | $2M | $2M | $3M | $2M | $2M | $2M | $1M | $2M | $1M | · | · | · | |
| Stockholders' Equity | $2.54B | $2.50B | $2.58B | $2.24B | $2.31B | $2.41B | $2.50B | $2.59B | $2.70B | · | · | · | |
| Liabilities + Equity | $2.84B | $2.80B | $2.92B | $2.60B | $2.70B | $2.85B | $2.98B | $3.12B | $3.27B | · | · | · | |
| Shares Outstanding | 44,666,234 | 41,134,219 | 40,331,360 | 36,160,998 | 36,047,799 | 35,296,858 | 33,893,409 | 33,203,744 | 31,049,148 | · | 0 | · |
Fluxo de Caixa 10
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $20M | $17M | $14M | $14M | $14M | $16M | $14M | $17M | $26M | $29M | $25M | $25M | |
| Deferred Tax | $-57M | $-35M | $-17M | $-30M | $-39M | $-40M | $-29M | $-47M | $-53M | $-5M | $-4M | $-18M | |
| Amort. of Intangibles | $33M | $33M | $30M | $35M | $33M | $33M | $30M | $35M | $35M | $35M | $30M | $35M | |
| Restructuring | · | · | · | · | · | · | · | $19M | · | · | · | · | |
| Operating Cash Flow | $-81M | $-87M | $-64M | $-63M | $-77M | $-95M | $-93M | $-105M | $-172M | $-207M | $-129M | $-158M | |
| CapEx | $432.0K | $503.0K | $94.0K | $384.0K | $369.0K | $62.0K | $303.0K | $971.0K | $1M | $3M | · | · | |
| Investing Cash Flow | $-47M | $-93M | $-237M | $67M | $70M | $15M | $-546M | $-971.0K | $-1M | $-3M | $-4M | $-3M | |
| Financing Cash Flow | · | · | $423M | $0 | $0 | $0 | $0 | $0 | $932M | $312M | $86M | $74M | |
| Net Change in Cash | $-14M | $-180M | $123M | $3M | $-6M | $-80M | $-640M | $-105M | $759M | $102M | $-47M | $-87M | |
| Free Cash Flow | · | $-87M | · | · | · | $-95M | · | · | · | · | · | · |
Lucratividade 7
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -388.9% | -332.9% | · | -346.2% | -446.9% | -482.5% | · | -640.5% | -5133.9% | · | · | · | |
| Net Margin | -246.7% | -228.5% | · | -245.8% | -320.7% | -333.6% | · | -438.7% | -4958.8% | · | · | · | |
| Pretax Margin | -373.1% | -312.7% | · | -328.0% | -430.1% | -459.9% | · | -601.7% | -5125.1% | · | · | · | |
| EBITDA Margin | -388.9% | -332.9% | · | -346.2% | -446.9% | -482.5% | · | -640.5% | -5133.9% | · | · | · | |
| ROA | -4.0% | -3.3% | · | -3.1% | -3.8% | -7.5% | · | -8.1% | -97.0% | · | · | · | |
| ROE | -4.5% | -3.8% | · | -3.7% | -4.5% | -8.8% | · | -9.7% | -117.6% | · | · | · | |
| ROIC | -4.5% | -4.0% | · | -4.2% | -5.1% | -4.6% | · | -5.2% | -58.9% | · | · | · |
Liquidez e Solvência 2
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.9 | 11.7 | · | 7.6 | 9.2 | 9.7 | · | 9.7 | 11.6 | · | · | · | |
| Quick Ratio | 0.9 | 1.2 | · | 1.8 | 2.0 | 2.0 | · | 9.1 | 10.9 | · | · | · |
Eficiência 2
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | |
| Receivables Turnover | 2.5 | 2.1 | · | 4.4 | 4.4 | 3.3 | · | · | · | · | · | · |
Avaliação (TTM) 10
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $157M | $144M | · | $132M | $128M | $119M | · | $108M | $102M | · | · | · | |
| Net Income TTM | $-406M | $-402M | · | $-435M | $-1.93B | $-2.04B | · | $-2.82B | $-2.89B | · | · | · | |
| Market Cap | $3.05B | $2.13B | · | $2.14B | $1.85B | $901M | · | $457M | $477M | · | · | · | |
| P/E | -6.5 | -4.7 | · | -4.7 | -0.8 | -0.4 | · | -0.2 | -0.2 | · | · | · | |
| P/S | 19.4 | 14.7 | · | 16.2 | 14.5 | 7.6 | · | 4.2 | 4.7 | · | · | · | |
| P/B | 1.2 | 0.9 | · | 1.0 | 0.8 | 0.4 | · | 0.2 | 0.2 | · | · | · | |
| P / Tangible Book | 4.0 | 3.1 | · | 6.0 | 4.7 | 2.1 | · | 0.9 | 0.8 | · | · | · | |
| P / Cash Flow | · | -24.4 | · | · | · | -9.5 | · | · | · | · | · | · | |
| P / FCF | · | -24.3 | · | · | · | -9.5 | · | · | · | · | · | · | |
| Earnings Yield | -15.4% | -21.3% | · | -21.4% | -119.2% | -255.1% | · | -659.6% | -605.3% | · | · | · |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-01-01 | |
|---|---|---|---|---|
| Receita | $147M | $126M | $93M | $56M |
| Margem Operacional % | -382.0% | -1743.0% | — | — |
| Lucro líquido | $-408M | $-2.03B | $-1.47B | $-5.40B |
| EPS Diluído | $-11.11 | $-63.54 | $-47.21 | $-173.89 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-01-01 | |
|---|---|---|---|---|
| Índice de liquidez corrente | 12.0 | 10.7 | — | — |
| Índice de Liquidez Seca | 3.4 | 3.0 | — | — |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-01-01 | |
|---|---|---|---|---|
| Fluxo de caixa livre | $-300M | $-582M | — | — |
Últimas notícias Notícias recentes mencionando esta empresa
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 411 declarantes · $2.2B total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 67 (+16 vs trimestre anterior) | 45 (-49 vs trimestre anterior) | 106 (+8 vs trimestre anterior) | 102 (-12 vs trimestre anterior) | +6.7M |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $284.111.340 | 4.161.584 | 13,20% | Ações |
| BAKER BROS. ADVISORS LP | $275.033.478 | 4.028.614 | 12,78% | Ações |
| STATE STREET CORP | $162.859.041 | 2.385.514 | 7,57% | Ações |
| PRIMECAP MANAGEMENT CO/CA/ | $148.835.838 | 2.180.106 | 6,91% | Ações |
| Sessa Capital IM, L.P. | $139.101.354 | 2.037.518 | 6,46% | Ações |
| Deep Track Capital, LP | $125.271.627 | 1.834.944 | 5,82% | Ações |
| VANGUARD CAPITAL MANAGEMENT LLC | $112.039.058 | 1.641.117 | 5,21% | Ações |
| Arbiter Partners Capital Management LLC | $70.611.456 | 1.034.297 | 3,28% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $58.460.697 | 856.182 | 2,72% | Ações |
| Jefferies Financial Group Inc. | $49.427.480 | 724.000 | 2,30% | Ações |
| Jefferies Financial Group Inc. | $44.375.500 | 650.000 | 2,06% | Opção de venda |
| DIMENSIONAL FUND ADVISORS LP | $43.707.751 | 640.219 | 2,03% | Ações |
| GOLDMAN SACHS GROUP INC | $42.579.111 | 623.687 | 1,98% | Ações |
| BANK OF AMERICA CORP /DE/ | $42.152.219 | 617.434 | 1,96% | Ações |
| Casdin Capital, LLC | $32.769.600 | 480.000 | 1,52% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $32.631.831 | 477.982 | 1,52% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $25.396.440 | 372.000 | 1,18% | Opção de compra |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $24.563.546 | 359.800 | 1,14% | Opção de venda |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $23.211.800 | 340.000 | 1,08% | Ações |
| Granahan Investment Management, LLC | $21.926.686 | 321.176 | 1,02% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $20.523.874 | 300.628 | 0,95% | Ações |
| Aberdeen Group plc | $15.668.170 | 229.503 | 0,73% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $15.357.337 | 224.950 | 0,71% | Ações |
| Slow Capital, Inc. | $14.832.477 | 217.262 | 0,69% | Ações |
| CITADEL ADVISORS LLC | $14.616.607 | 214.100 | 0,68% | Opção de compra |
| TCW GROUP INC | $13.101.901 | 191.913 | 0,61% | Ações |
| Douglas Lane & Associates, LLC | $11.082.952 | 162.340 | 0,51% | Ações |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $10.601.990 | 155.295 | 0,49% | Ações |
| RAYMOND JAMES FINANCIAL INC | $10.495.215 | 153.731 | 0,49% | Ações |
| Newtyn Management, LLC | $10.240.500 | 150.000 | 0,48% | Ações |
| 180 WEALTH ADVISORS, LLC | $8.723.113 | 127.774 | 0,41% | Ações |
| Voleon Capital Management LP | $8.264.903 | 121.062 | 0,38% | Ações |
| FMR LLC | $8.139.559 | 119.226 | 0,38% | Ações |
| WIM INVESTMENT MANAGEMENT Ltd | $7.263.928 | 106.400 | 0,34% | Ações |
| Alyeska Investment Group, L.P. | $7.168.350 | 105.000 | 0,33% | Ações |
| AMERICAN CENTURY COMPANIES INC | $6.774.228 | 99.227 | 0,31% | Ações |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $5.809.000 | 85.089 | 0,27% | Ações |
| Swiss National Bank | $5.202.174 | 76.200 | 0,24% | Ações |
| Susquehanna Portfolio Strategies, LLC | $4.853.178 | 71.088 | 0,23% | Ações |
| NATIXIS | $4.794.329 | 70.226 | 0,22% | Ações |
| CITADEL ADVISORS LLC | $4.601.398 | 67.400 | 0,21% | Opção de venda |
| BARCLAYS PLC | $4.557.091 | 66.751 | 0,21% | Ações |
| GAMCO INVESTORS, INC. ET AL | $4.554.497 | 66.713 | 0,21% | Ações |
| D. E. Shaw & Co., Inc. | $4.444.787 | 65.106 | 0,21% | Ações |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3.810.968 | 55.822 | 0,18% | Ações |
| Allianz Asset Management GmbH | $3.810.695 | 55.818 | 0,18% | Ações |
| JANE STREET GROUP, LLC | $3.775.331 | 55.300 | 0,18% | Opção de compra |
| RHUMBLINE ADVISERS | $3.773.202 | 55.269 | 0,18% | Ações |
| Public Sector Pension Investment Board | $3.633.534 | 53.223 | 0,17% | Ações |
| Pictet Asset Management Holding SA | $3.421.492 | 50.039 | 0,16% | Ações |
| Centiva Capital, LP | $3.413.500 | 50.000 | 0,16% | Opção de compra |
| Verition Fund Management LLC | $3.334.921 | 48.849 | 0,15% | Ações |
| BlackRock, Inc. | $3.131.886 | 45.875 | 0,15% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $3.072.150 | 450 | 0,14% | Opção de compra |
| D. E. Shaw & Co., Inc. | $3.072.150 | 45.000 | 0,14% | Opção de venda |
| Legal Advantage Investments, Inc. | $3.046.549 | 44.625 | 0,14% | Ações |
| HighTower Advisors, LLC | $2.769.342 | 40.565 | 0,13% | Ações |
| Rafferty Asset Management, LLC | $2.697.962 | 39.519 | 0,13% | Ações |
| Timelo Investment Management Inc. | $2.662.530 | 39.000 | 0,12% | Ações |
| ALLIANCEBERNSTEIN L.P. | $2.492.320 | 48.226 | 0,12% | Ações |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2.298.210 | 44.470 | 0,11% | Ações |
| Lido Advisors, LLC | $2.270.250 | 33.254 | 0,11% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $2.252.910 | 330 | 0,10% | Opção de venda |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $2.211.768 | 30.719 | 0,10% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $2.133.984 | 31.258 | 0,10% | Ações |
| Summit Financial, LLC | $2.103.877 | 30.817 | 0,10% | Ações |
| GABELLI FUNDS LLC | $2.067.420 | 30.283 | 0,10% | Ações |
| JONES FINANCIAL COMPANIES LLLP | $1.988.740 | 30.169 | 0,09% | Ações |
| OSAIC HOLDINGS, INC. | $1.906.981 | 27.934 | 0,09% | Ações |
| TWO SIGMA INVESTMENTS, LP | $1.872.305 | 27.425 | 0,09% | Ações |
| COMMERCE BANK | $1.841.993 | 26.981 | 0,09% | Ações |
| UBS Group AG | $1.835.234 | 26.882 | 0,09% | Ações |
| Concurrent Investment Advisors, LLC | $1.833.850 | 26.862 | 0,09% | Ações |
| Gem Investment Advisors, LLC | $1.828.339 | 26.781 | 0,08% | Ações |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.823.765 | 26.714 | 0,08% | Ações |
| Legato Capital Management LLC | $1.804.649 | 26.434 | 0,08% | Ações |
| PVG ASSET MANAGEMENT CORP | $1.767.305 | 25.887 | 0,08% | Ações |
| CANADA PENSION PLAN INVESTMENT BOARD | $1.761.366 | 25.800 | 0,08% | Ações |
| IMC-Chicago, LLC | $1.710.368 | 25.053 | 0,08% | Ações |
| Jackson Hole Capital Partners, LLC | $1.705.440 | 33.000 | 0,08% | Ações |
| Sheets Smith Investment Management | $1.688.635 | 28.558 | 0,08% | Ações |
| MetLife Investment Management, LLC | $1.649.813 | 24.166 | 0,08% | Ações |
| Gotham Asset Management, LLC | $1.634.384 | 23.940 | 0,08% | Ações |
| Quantinno Capital Management LP | $1.593.922 | 23.347 | 0,07% | Ações |
| TWO SIGMA ADVISERS, LP | $1.592.060 | 18.601 | 0,07% | Ações |
| CLOUGH CAPITAL PARTNERS L P | $1.566.387 | 22.944 | 0,07% | Ações |
| STATE OF WISCONSIN INVESTMENT BOARD | $1.522.353 | 22.299 | 0,07% | Ações |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1.474.427 | 21.597 | 0,07% | Ações |
| LPL Financial LLC | $1.393.254 | 20.408 | 0,06% | Ações |
| PROFUND ADVISORS LLC | $1.370.725 | 20.078 | 0,06% | Ações |
| Perigon Wealth Management, LLC | $1.348.537 | 19.753 | 0,06% | Ações |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $1.271.324 | 18.622 | 0,06% | Ações |
| Invesco Ltd. | $1.117.853 | 16.374 | 0,05% | Ações |
| Bouvel Investment Partners, LLC | $1.106.998 | 16.215 | 0,05% | Ações |
| AMERIPRISE FINANCIAL INC | $1.082.216 | 15.852 | 0,05% | Ações |
| NORGES BANK | $1.077.983 | 15.790 | 0,05% | Ações |
| EXCHANGE TRADED CONCEPTS, LLC | $1.054.703 | 15.449 | 0,05% | Ações |
| STRS OHIO | $1.044.531 | 15.300 | 0,05% | Ações |
| PRUDENTIAL FINANCIAL INC | $1.006.300 | 14.740 | 0,05% | Ações |
| NEW YORK STATE COMMON RETIREMENT FUND | $996.469 | 14.596 | 0,05% | Ações |
Executivos da empresa 8 insiders · 2 diretores · 5 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Joshua J. Ofman | Chief Executive Officer | 1 de Junho de 2026 A | 402.271 | 0 | 0 | $0 |
| Andrew John Partridge | Chief Growth Officer | 4 de Junho de 2026 S | 163.738 | 0 | 1 | $-91.070 |
| William J Chase | Conselheiro | 15 de Julho de 2026 A | 42.978 | 0 | 0 | $0 |
| Steven Mizell | Conselheiro | 15 de Julho de 2026 A | 42.830 | 0 | 0 | $0 |
| Gregory L Summe | Conselheiro | 15 de Julho de 2026 A | 45.672 | 0 | 0 | $0 |
| Sarah Krevans | Conselheiro | 18 de Junho de 2026 A | 42.628 | 0 | 0 | $0 |
| ILLUMINA, INC. | Detentor de 10% | 17 de Novembro de 2025 S | 3.502.126 | 0 | 1 | $-79.850.000 |
| Chun R Ding | Detentor de 10% | 9 de Outubro de 2024 P | 3.644.855 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Participação em ETFs Detido por 50 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,90% | 18.597 NS | 30 de Abril de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,63% | 59.651 NS | 30 de Abril de 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,21% | 87.481 SH | 8 de Agosto de 2026 | Diário |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,20% | 2.336 SH | 8 de Agosto de 2026 | Diário |
| IBB · iShares Trust | 0,19% | 291.644 SH | 8 de Agosto de 2026 | Diário |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,18% | 36.116 SH | 8 de Agosto de 2026 | Diário |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,17% | 67.501 NS | 31 de Maio de 2026 | N-PORT |
| IWN · iShares Trust | 0,17% | 385.837 SH | 8 de Agosto de 2026 | Diário |
| ESSC · Strategy Shares | 0,15% | 712 NS | 30 de Abril de 2026 | N-PORT |
| BIB · ProShares Trust | 0,14% | 1.439 NS | 31 de Maio de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,09% | 237.749 SH | 8 de Agosto de 2026 | Diário |
| IWM · iShares Trust | 0,08% | 1.053.632 SH | 8 de Agosto de 2026 | Diário |
| GSSC · Goldman Sachs ETF Trust | 0,08% | 11.051 NS | 31 de Maio de 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,08% | 1.185 NS | 30 de Abril de 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 9.665 NS | 30 de Abril de 2026 | N-PORT |
| ITWO · ProShares Trust | 0,06% | 1.654 NS | 31 de Maio de 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,06% | 2.459 SH | 8 de Agosto de 2026 | Diário |
| RSSL · Global X Funds | 0,06% | 15.208 NS | 30 de Abril de 2026 | N-PORT |
| ESML · iShares Trust | 0,05% | 22.118 SH | 8 de Agosto de 2026 | Diário |
| DFAS · Dimensional ETF Trust | 0,05% | 117.357 NS | 30 de Abril de 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,05% | 143.168 NS | 31 de Maio de 2026 | N-PORT |
| ISCG · iShares Trust | 0,04% | 6.428 SH | 8 de Agosto de 2026 | Diário |
| VHT · VANGUARD WORLD FUND | 0,04% | 114.187 SH | 8 de Agosto de 2026 | Diário |
| UWM · ProShares Trust | 0,04% | 1.294 NS | 31 de Maio de 2026 | N-PORT |
| ISCB · iShares Trust | 0,04% | 1.688 SH | 8 de Agosto de 2026 | Diário |
| ISCV · iShares Trust | 0,04% | 3.927 SH | 8 de Agosto de 2026 | Diário |
| SMLF · iShares Trust | 0,03% | 20.757 SH | 8 de Agosto de 2026 | Diário |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 16.096 NS | 30 de Abril de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 374.291 SH | 8 de Agosto de 2026 | Diário |
| URTY · ProShares Trust | 0,03% | 1.307 NS | 31 de Maio de 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 2.078 SH | 8 de Agosto de 2026 | Diário |
| DXUV · Dimensional ETF Trust | 0,02% | 1.178 NS | 30 de Abril de 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 1.399 NS | 31 de Maio de 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,01% | 23.351 NS | 31 de Maio de 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 33 NS | 31 de Maio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 4.910 NS | 30 de Abril de 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 11.015 NS | 31 de Maio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 51.657 NS | 30 de Abril de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 11.704 SH | 8 de Agosto de 2026 | Diário |
| IETC · iShares U.S. ETF Trust | 0,00% | 375 SH | 8 de Agosto de 2026 | Diário |
| ACVF · ETF Opportunities Trust | 0,00% | 82 NS | 30 de Abril de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 45.817 SH | 8 de Agosto de 2026 | Diário |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,00% | 192 NS | 31 de Maio de 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 17.955 NS | 31 de Maio de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 9.362 NS | 30 de Abril de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 4.660 NS | 30 de Abril de 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,00% | 3.550 NS | 30 de Abril de 2026 | N-PORT |
| DFLV · Dimensional ETF Trust | 0,00% | 321 NS | 30 de Abril de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.228.926 SH | 8 de Agosto de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.407 SH | 8 de Agosto de 2026 | Diário |